Artelo Biosciences reported earnings of -$ 3.19 per ARTL share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 7.02 |
| Earnings Per Share (Surprise) | -$ 3.19 (+$ 3.83) |
| Last Year's EPS | -$ 19.77 |
| EPS YoY Change |
Out of the last 55 earnings reporting periods, Artelo Biosciences beat analysts’ expectations 10 times and fell short of expectations 23 time(s). Artelo Biosciences reported earnings per share of -$ 3.19 in the last report surpassing an estimated EPS of -$ 7.02 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 7.02 | -$ 3.19 | -$ 11.91 | |
| Aug 12, 2026 | -$ 6.48 | -$ 8.01 | -$ 50.49 | |
| May 14, 2026 | -$ 0.78 | -$ 4.00 | -$ 16.83 | |
| Feb 24, 2026 | -$ 4.71 | -$ 6.66 | -$ 12.96 | |
| Nov 12, 2025 | -$ 2.46 | -$ 11.91 | -$ 21.06 | |
| Aug 13, 2025 | -$ 37.71 | -$ 50.49 | -$ 63.18 | |
| Aug 12, 2025 | -$ 12.57 | -$ 16.83 | -$ 3.15 | |
| May 13, 2025 | -$ 2.40 | -$ 12.96 | -$ 6.75 | |
| Mar 24, 2025 | -$ 6.66 | -$ 21.06 | -$ 126.36 | |
| Mar 3, 2025 | -$ 23.58 | -$ 63.18 | -$ 9.36 | |
| Nov 12, 2024 | -$ 4.14 | -$ 3.15 | -$ 53.46 | |
| Aug 13, 2024 | -$ 7.65 | -$ 6.75 | -$ 7.47 | |
| May 13, 2024 | -$ 9.45 | -$ 126.36 | -$ 5.04 | |
| Mar 29, 2024 | -$ 5.04 | -$ 9.36 | -$ 6.84 | |
| Mar 25, 2024 | -$ 30.06 | -$ 53.46 | -$ 6.03 | |
| Nov 13, 2023 | -$ 5.85 | -$ 7.47 | -$ 10.62 | |
| Aug 10, 2023 | -$ 7.29 | -$ 5.04 | -$ 7.38 | |
| May 11, 2023 | -$ 8.37 | -$ 6.84 | -$ 8.10 | |
| Apr 17, 2023 | -$ 6.57 | -$ 6.03 | -$ 6.75 | |
| Mar 31, 2023 | -$ 6.57 | -$ 10.62 | -$ 21.59 |
Artelo Biosciences’s stock was trading at $ 2.20 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, ARTL’s price decreased to $ 2.07 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 3.19 | $ 2.20 | $ 2.07 | |
| Aug 12, 2026 | -$ 8.01 | $ 6.70 | $ 6.83 | |
| May 14, 2026 | -$ 4.00 | $ 20.79 | $ 16.56 | |
| Feb 24, 2026 | -$ 6.66 | $ 33.48 | $ 32.67 | |
| Nov 12, 2025 | -$ 11.91 | $ 17.64 | $ 16.20 | |
| Aug 13, 2025 | -$ 50.49 | $ 87.48 | $ 90.81 | |
| Aug 12, 2025 | -$ 16.83 | $ 90.27 | $ 91.17 | |
| May 13, 2025 | -$ 12.96 | $ 54.00 | $ 53.73 | |
| Mar 24, 2025 | -$ 21.06 | $ 56.16 | $ 52.47 | |
| Mar 3, 2025 | -$ 63.18 | $ 57.78 | $ 55.62 | |
| Nov 12, 2024 | -$ 3.15 | $ 66.96 | $ 59.40 | |
| Aug 13, 2024 | -$ 6.75 | $ 68.04 | $ 71.28 | |
| May 13, 2024 | -$ 126.36 | $ 72.36 | $ 71.82 | |
| Mar 29, 2024 | -$ 9.36 | $ 79.92 | $ 82.08 | |
| Mar 25, 2024 | -$ 53.46 | $ 82.08 | $ 77.76 | |
| Nov 13, 2023 | -$ 7.47 | $ 68.58 | $ 70.74 | |
| Aug 10, 2023 | -$ 5.04 | $ 106.38 | $ 103.68 | |
| May 11, 2023 | -$ 6.84 | $ 92.34 | $ 90.18 | |
| Apr 17, 2023 | -$ 6.03 | $ 140.94 | $ 147.42 | |
| Mar 31, 2023 | -$ 10.62 | $ 116.10 | $ 134.46 |
Artelo Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Artelo Biosciences beat analysts’ expectations during the last earnings period by
